Vor Biopharma Inc. (NasdaqGS: VOR)
Health Care · Biotechnology · US
$19.89
-0.05% today · -38.4% 1Y
Vor Biopharma Inc. (NasdaqGS: VOR) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.18B and employs 76 people.
Over the last twelve months the share price has lost 38.4%, trading between 6.50 and 33.50.
Tweenvest scores Vor Biopharma Inc. across four factors: quality 31/100, value 75/100. Its strongest factor is value.
VOR price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.18B
- Revenue (TTM)
- —
- P/E
- 0.99
- EPS
- 20.19
- Dividend yield
- —
- Beta (5Y)
- 1.78
- 52-week high
- $33.50
- 52-week low
- $6.50
- Avg volume (3M)
- —
- Shares outstanding
- 59.16M
- Employees
- 76
- Next earnings
- —
About Vor Biopharma Inc.
Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is their engineered absence of the CD33 protein, which is commonly found on AML blood cancer cells. The company's eHSC platform is intended to enable a range of targeted blood cancer treatments, including CAR-T cell therapies, bispecific antibodies, and antibody-drug conjugates. Vor Biopharma has established a partnership with Akron BioProducts for the development and manufacturing of cGMP nucleases. Established in 2015, the company's headquarters are located in Cambridge, Massachusetts.
- ISIN
- US9290332074
- Founded
- 2015
- Listed since
- Feb 5, 2021
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Suzhou Ribo Life Science Co., Ltd.SEHK: 6938 | $1.21B | HK$55.90 | +2.95% |
| Nanobiotix S.A.ENXTPA: NANO | $1.21B | €21.24 | +3.51% |
| Bio-Thera Solutions, Ltd.SHSE: 688177 | $1.19B | CN¥19.30 | -8.23% |
| BioGaia AB (publ)OM: BIOG B | $1.18B | Skr116.80 | +1.21% |
| NatureCell Co.,Ltd.KOSDAQ: A007390 | $1.18B | ₩24,550.00 | -0.81% |
| HBM Holdings LimitedSEHK: 2142 | $1.17B | HK$11.14 | -17.11% |
| Aimed Bio Inc.KOSDAQ: A0009K0 | $1.17B | ₩24,250.00 | -2.22% |
| Bicara Therapeutics Inc.NasdaqGM: BCAX | $1.16B | $17.25 | -1.43% |
Figures last refreshed Oct 11, 2026.